Skip to main content
. 2013 Dec 2;110(51):E4978–E4986. doi: 10.1073/pnas.1315370110

Fig. 1.

Fig. 1.

Schematic approach. A total of 85 putative ovarian cancer protein markers were identified through literature, database, and other screens (Upper Left). Markers were tested in 12 ovarian cell lines (SI Appendix, Fig. S1), and a subset were examined in ascites from human patients (Lower Left; n = 65) (Figs. 2 and 3). A microfluidic chip (Fig. 4) was developed for point-of-care analysis (Lower Right).